Safety of anticonvulsant agents in pregnancy

Bibliography

• Kotsopoulos IA, van Merode T, Kessels FG, et al. Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia 2002;43(11):1402-9
   PubMed Web of Science ®Google Scholar
• Hart LA, Sibai BM. Seizures in pregnancy: epilepsy, eclampsia, and stroke. Semin Perinatol 2013;37(4):207-24
   PubMed Web of Science ®Google Scholar
• Harden CL, Hopp J, Ting TY, et al. Practice parameter update: management issues for women with epilepsy–focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the quality standards subcommittee and therapeutics and technology assessment subcommittee of the American academy of neurology and American epilepsy society. Neurology 2009;73(2):126-32
   PubMed Web of Science ®Google Scholar
• Kaplan PW, Norwitz ER, Ben-Menachem E, et al. Obstetric risks for women with epilepsy during pregnancy. Epilepsy Behav 2007;11(3):283-91
   PubMed Web of Science ®Google Scholar
• Yerby MS. Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology 2000;55(5 Suppl 1):S21-31. discussion S54-8
   PubMed Web of Science ®Google Scholar
• Harden CL, Sethi NK. Epileptic disorders in pregnancy: an overview. Curr opin Obstet Gynecol 2008;20(6):557-62
   PubMed Web of Science ®Google Scholar
• Harden CL, Pennell PB, Koppel BS, et al. Practice parameter update: management issues for women with epilepsy–focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the quality standards subcommittee and therapeutics and technology assessment subcommittee of the American academy of neurology and American epilepsy society. Neurology 2009;73(2):142-9
   PubMed Web of Science ®Google Scholar
• Panayiotopoulos CP. The new ILAE report on terminology and concepts for the organization of epilepsies: critical review and contribution. Epilepsia 2012;53(3):399-404
   PubMed Web of Science ®Google Scholar
• Cherian A, Thomas SV. Status epilepticus. Ann Indian Acad Neurol 2009;12(3):140-53
   PubMed Web of Science ®Google Scholar
• Krumholz A, Wiebe S, Gronseth G, et al. Practice Parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review): report of the quality standards subcommittee of the American academy of neurology and the American epilepsy society. Neurology 2007;69(21):1996-2007
   PubMed Web of Science ®Google Scholar
• Cagnetti C, Lattanzi S, Foschi N, et al. Seizure course during pregnancy in catamenial epilepsy. Neurology 2014;83(4):339-44
   PubMed Web of Science ®Google Scholar
• Sveberg L, Svalheim S, Tauboll E. The impact of seizures on pregnancy and delivery. Seizure 2015;35-8
   PubMed Web of Science ®Google Scholar
• Hirsch LJ, Gaspard N. Status epilepticus. Continuum (Minneap Minn) 2013;19(3 Epilepsy):767-94
   PubMedGoogle Scholar
• Edey S, Moran N, Nashef L. SUDEP and epilepsy-related mortality in pregnancy. Epilepsia 2014;55(7):e72-4
   PubMed Web of Science ®Google Scholar
• Adab N. Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful? CNS Drugs 2006;20(10):791-800
   PubMed Web of Science ®Google Scholar
• Jentink J, Loane MA, Dolk H, et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 2010;362(23):2185-93
   PubMed Web of Science ®Google Scholar
• Wlodarczyk BJ, Palacios AM, George TM, Finnell RH. Antiepileptic drugs and pregnancy outcomes. Am J Med GenetA 2012;158A(8):2071-90
   Google Scholar
• Hernandez-Diaz S, Smith CR, Shen A, et al. Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012;78(21):1692-9
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009;360(16):1597-605
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Browning N, et al. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA pediatrics 2014;168(8):729-36
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurology 2013;12(3):244-52
   PubMed Web of Science ®Google Scholar
• Vajda FJ, O’Brien T, Lander C, et al. The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy. Epilepsia 2014;55(8):1229-34
   PubMed Web of Science ®Google Scholar
• Cunnington MC, Weil JG, Messenheimer JA, et al. Final results from 18 years of the international lamotrigine pregnancy registry. Neurology 2011;76(21):1817-23
   PubMed Web of Science ®Google Scholar
• Cummings C, Stewart M, Stevenson M, et al. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis child 2011;96(7):643-7
   PubMed Web of Science ®Google Scholar
• Westin AA, Nakken KO, Johannessen SI, et al. Serum concentration/dose ratio of topiramate during pregnancy. Epilepsia 2009;50(3):480-5
   PubMed Web of Science ®Google Scholar
• Thomas SV, Syam U, Devi JS. Predictors of seizures during pregnancy in women with epilepsy. Epilepsia 2012;53(5):e85-8
   PubMed Web of Science ®Google Scholar
• Walker SP, Permezel M, Berkovic SF. The management of epilepsy in pregnancy. BJOG 2009;116(6):758-67
   PubMed Web of Science ®Google Scholar
• Pennell PB, Peng L, Newport DJ, et al. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology 2008;70(22 Pt 2):2130-6
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Browning N, et al. Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology 2010;75(22):1954-60
   PubMed Web of Science ®Google Scholar
• Dutton C, Foldvary-Schaefer N. Contraception in women with epilepsy: pharmacokinetic interactions, contraceptive options, and management. Int Rev Neurobiol 2008;83:113-34
   PubMed Web of Science ®Google Scholar
• Liu S, Joseph KS, Liston RM, et al. Incidence, risk factors, and associated complications of eclampsia. Obstet Gynecol 2011;118(5):987-94
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol 2013;122(5):1122-31
   PubMed Web of Science ®Google Scholar
• Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005;105(2):402-10
   PubMed Web of Science ®Google Scholar
• Mattar F, Sibai BM. Prevention of preeclampsia. Semin Perinatol 1999;23(1):58-64
   PubMed Web of Science ®Google Scholar
• Witlin AG, Saade GR, Mattar F, Sibai BM. Risk factors for abruptio placentae and eclampsia: analysis of 445 consecutively managed women with severe preeclampsia and eclampsia. Am J Obstet Gynecol 1999;180(6 Pt 1):1322-9
   PubMed Web of Science ®Google Scholar
• Mattar F, Sibai BM. Eclampsia. VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol 2000;182(2):307-12
   PubMed Web of Science ®Google Scholar
• Cooray SD, Edmonds SM, Tong S, et al. Characterization of symptoms immediately preceding eclampsia. Obstet Gynecol 2011;118(5):995-9
   PubMed Web of Science ®Google Scholar
• Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334(8):494-500
   PubMed Web of Science ®Google Scholar
• Hinchey JA. Reversible posterior leukoencephalopathy syndrome: what have we learned in the last 10 years? Arch Neurol 2008;65(2):175-6
   PubMed Web of Science ®Google Scholar
• Brewer J, Owens MY, Wallace K, et al. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol 2013;208(6):468e1-6
   Web of Science ®Google Scholar
• Sibai BM. The magpie trial. Lancet 2002;360(9342):1329; author reply 31-2
   PubMed Web of Science ®Google Scholar
• Magpie Trial Follow-Up Study Collaborative G. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG 2007;114(3):289-99
   PubMed Web of Science ®Google Scholar
• Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2010;11:CD000025
   PubMed Web of Science ®Google Scholar
• Duley L, Henderson-Smart DJ, Chou D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev 2010(10):CD000128
   PubMed Web of Science ®Google Scholar
• Duley L, Henderson-Smart DJ, Walker GJ, Chou D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev 2010(12):CD000127
   Google Scholar
• Duley L, Matar HE, Almerie MQ, Hall DR. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. Cochrane Database Syst Rev 2010(8):CD007388
   Google Scholar
• Tomson T, Perucca E, Battino D. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy. Epilepsia 2004;45(10):1171-5
   PubMed Web of Science ®Google Scholar
• EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 2006;66(3):354-60
   PubMed Web of Science ®Google Scholar
• Zhang H, Yang D, Yang H, Liu H. [Effect on conception and offspring development in female parenatal rats following intratracheal instillation of nano-C/ZnO and C-ZnO composite nanoparticles]. Wei Sheng Yan Jiu 2008;37(6):654-6
   PubMedGoogle Scholar
• Raymond GV, Buehler BA, Finnell RH, Holmes LB. Anticonvulsant teratogenesis: 3. Possible metabolic basis. Teratology 1995;51(2):55-6
   PubMedGoogle Scholar
• Sanchez O, Llurba E, Marsal G, et al. First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology. Hum Reprod 2012;27(2):358-65
   PubMed Web of Science ®Google Scholar
• Wegner C, Nau H. Diurnal variation of folate concentrations in mouse embryo and plasma: the protective effect of folinic acid on valproic-acid-induced teratogenicity is time dependent. Reprod Toxicol 1991;5(6):465-71
   PubMed Web of Science ®Google Scholar
• Tiboni GM, Giampietro F, Angelucci S, et al. Additional investigation on the potentiation of phenytoin teratogenicity by fluconazole. Toxicol Lett 2003;145(3):219-29
   PubMed Web of Science ®Google Scholar
• Amicarelli F, Tiboni GM, Colafarina S, et al. Antioxidant and GSH-related enzyme response to a single teratogenic exposure to the anticonvulsant phenytoin: temporospatial evaluation. Teratology 2000;62(2):100-7
   PubMedGoogle Scholar
• Guttmacher AE, Maddox YT, Spong CY. The Human Placenta Project: placental structure, development, and function in real time. Placenta 2014;35(5):303-4
   PubMed Web of Science ®Google Scholar
• Samrén EB, van Duijn CM, Christiaens GC, Hofman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999;46(5):739-46
   PubMed Web of Science ®Google Scholar
• Kaneko S, Battino D, Andermann E, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999;33(2-3):145-58
   PubMed Web of Science ®Google Scholar
• Holmes LB, Mittendorf R, Shen A, Smith CR, Hernandez-Diaz S. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Archives of neurology 2011;68(10):1275-81
   PubMed Web of Science ®Google Scholar
• Montouris G. Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav 2003;4(3):310-7
   PubMed Web of Science ®Google Scholar
• Artama M, Ritvanen A, Gissler M, Isojärvi J, Auvinen A. Congenital structural anomalies in offspring of women with epilepsy–a population-based cohort study in Finland. Int J Epidemiol 2006;35(2):280-7
   PubMed Web of Science ®Google Scholar
• Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77(2):193-8
   PubMed Web of Science ®Google Scholar
• Vajdar FJ, Hitchcock A, Graham J, et al. Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. Eur J Neurol 2006;13(6):645-54
   PubMed Web of Science ®Google Scholar
• Mawer G, Briggs M, Baker GA, et al. Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure 2010;19(2):112-9
   PubMed Web of Science ®Google Scholar
• Vajda FJ, Graham J, Roten A, Lander CM, O’Brien TJ, Eadie M. Teratogenicity of the newer antiepileptic drugs--the Australian experience. J Clin Neurosci 2012;19(1):57-9
   PubMed Web of Science ®Google Scholar